Cash In on One of Our Biggest Biotech Winners
March 10, 2015 at 05:00 AM EDT
Back in early April 2012, in a special report for Private Briefing readers called "The Biotech Buyout Binge," I explained that we would start seeing a slew of takeovers – engineered by cash-rich biopharmaceutical firms desperate to replace blockbusters that were losing patent protection. We were right about the so-called "patent cliff." Here's how to play one […] The post Cash In on One of Our Biggest Biotech Winners appeared first on Money Morning - We Make Investing Profitable .